Serial Number
97391380
Owner
Retriever Medical, Inc.Attorney
Susan Piascik ChristoffFirst Use Date
Jan 15, 2023
Filing Date
May 2, 2022
CLOTHOUND BLUE Trademark
Serial Number: 97391380 • Registration: 7445582
Trademark Classes
Owner Contact Info
10845 Griffith Peak Drive
Las Vegas, NV 89135
Entity Type: 03
Legal Representation
Correspondence Address
Susan Piascik Christoff Cooley LLP
1299 Pennsylvania Avenue, NW, Suite 700
ATTN: IP Docketing Department
Washington, DC 20004-2400
United States
Trademark Details
Filing Date
May 2, 2022
Registration Date
July 16, 2024
First Use Anywhere
January 15, 2023
First Use in Commerce
January 15, 2023
Published for Opposition
April 30, 2024
Goods & Services
Medical devices, namely, catheters for removal of occlusions from vessels, bronchial pathways; Medical devices, namely, cannulas and catheters for removing clot, thrombus, and other undesirable material; medical devices, namely, catheters used for removal of a thrombus; medical devices, namely, catheters for the therapeutic treatment of pulmonary embolism and deep vein thrombosis; Medical devices, namely, retrievers for use in radiology, neuroradiology, cardiology, and surgery, for treating pulmonary embolism and peripheral arterial disease, and surgical devices in the nature of retrievers for performing thrombectomy and retrieval of emboli, clots and foreign bodies; surgical devices, namely, thrombectomy devices and structural parts therefor; catheters; Medical devices, namely, access catheters for providing controlled fluid access to the body; medical instruments in the nature of a valve and hub system for connection and disconnection of suction to an aspiration catheter; medical instruments in the nature of a valve and hub system for achieving hemostasis during removal of an occlusion or thrombus; Medical devices, namely, catheters for application of aspiration during a medical procedure; Medical devices, namely, catheters for application of aspiration during thrombectomy, pulmonary embolism removal and retrieval, peripheral arterial disease treatment procedures, and large bore femoral closure procedures, all of the foregoing for use in humans
